Wound Management Technologies, Inc. (WNDM) Reports

Publication of Clinical Trial Data from CellerateRX(R) Surgical Activated Collagen(R) Peptides


WNDM Medical Inc. (: WNDM) today announced the publication of a journal article in Orthopedics: ”The Effects of Platelet-Rich Plasma and Activated Collagen on Wound Healing in Primary Total Joint Arthroplasty” by David Evans, BA and Bruce Evans, MD. This study examined whether two wound additives, platelet-rich plasma (PRP) and activated collagen (CellerateRX Surgical), would improve postoperative wound healing and reduce complications after total knee or hip replacement surgery.


Based in Fort Worth, Texas, WNDM Medical Inc. (WNDM) has a management team in place with significant healthcare industry experience that is committed to sales growth by providing efficacious products to improve patient outcomes.


Key Points from the Publication


• This was an unsponsored, institutional review board (IRB)-approved, prospective, randomized, single-blinded, controlled study with three cohorts of 30 patients each … read more